Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Parniak

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
The International Journal of Biochemistry & Cell Biology|June 9, 2004
Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formationNicolas Sluis-Cremer, Dominique Arion, Michael E Abram, et al.
Journal of Inclusion Phenomena and Macrocyclic Chemistry|June 23, 2015
A thermodynamic study of the cyclodextrin-UC781 inclusion complex using a HPLC methodHaitao Yang, Michael A Parniak, Sharon L Hillier, et al.
The Journal of Biological Chemistry|March 20, 2002
Primer unblocking and rescue of DNA synthesis by azidothymidine (AZT)-resistant HIV-1 reverse transcriptase: comparison between initiation and elongation of reverse transcription and between (-) and (+) strand DNA synthesisMickael Rigourd, Chantal Ehresmann, Michael A Parniak, et al.
Biology|April 20, 2013
Inhibitors of HIV-1 Reverse Transcriptase-Associated Ribonuclease H ActivityTatiana Ilina, Krystal Labarge, Stefan G Sarafianos, et al.
Biochemistry|January 17, 2007
3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptaseSanjeewa Dharmasena, Zita Pongracz, Eddy Arnold, et al.
AAPS Pharmscitech|August 15, 2019
Nanocrystal Formulation Improves Vaginal Delivery of CSIC for HIV PreventionTiantian Gong, Sravan Kumar Patel, Michael A Parniak, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Oligonucleotides comprised of alternating 2'-deoxy-2'-fluoro-beta-D-arabinonucleosides and D-2'-deoxyribonucleosides (2'F-ANA/DNA 'altimers') induce efficient RNA cleavage mediated by RNase HKyung-Lyum Min, Ekaterina Viazovkina, Annie Galarneau, et al.
The AAPS Journal|December 18, 2008
Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781Haitao Yang, Michael A Parniak, Charles E Isaacs, et al.
International Journal of Pharmaceutics|December 17, 2013
Development of a vaginal delivery film containing EFdA, a novel anti-HIV nucleoside reverse transcriptase inhibitorWei Zhang, Michael A Parniak, Stefan G Sarafianos, et al.
European Journal of Pharmacology|April 3, 2014
In vitro transport characteristics of EFdA, a novel nucleoside reverse transcriptase inhibitor using Caco-2 and MDCKII cell monolayersWei Zhang, Michael A Parniak, Stefan G Sarafianos, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
The International Journal of Biochemistry & Cell Biology|June 9, 2004
Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formationNicolas Sluis-Cremer, Dominique Arion, Michael E Abram, et al.
Journal of Inclusion Phenomena and Macrocyclic Chemistry|June 23, 2015
A thermodynamic study of the cyclodextrin-UC781 inclusion complex using a HPLC methodHaitao Yang, Michael A Parniak, Sharon L Hillier, et al.
The Journal of Biological Chemistry|March 20, 2002
Primer unblocking and rescue of DNA synthesis by azidothymidine (AZT)-resistant HIV-1 reverse transcriptase: comparison between initiation and elongation of reverse transcription and between (-) and (+) strand DNA synthesisMickael Rigourd, Chantal Ehresmann, Michael A Parniak, et al.
Biology|April 20, 2013
Inhibitors of HIV-1 Reverse Transcriptase-Associated Ribonuclease H ActivityTatiana Ilina, Krystal Labarge, Stefan G Sarafianos, et al.
Biochemistry|January 17, 2007
3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptaseSanjeewa Dharmasena, Zita Pongracz, Eddy Arnold, et al.
AAPS Pharmscitech|August 15, 2019
Nanocrystal Formulation Improves Vaginal Delivery of CSIC for HIV PreventionTiantian Gong, Sravan Kumar Patel, Michael A Parniak, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Oligonucleotides comprised of alternating 2'-deoxy-2'-fluoro-beta-D-arabinonucleosides and D-2'-deoxyribonucleosides (2'F-ANA/DNA 'altimers') induce efficient RNA cleavage mediated by RNase HKyung-Lyum Min, Ekaterina Viazovkina, Annie Galarneau, et al.
The AAPS Journal|December 18, 2008
Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781Haitao Yang, Michael A Parniak, Charles E Isaacs, et al.
International Journal of Pharmaceutics|December 17, 2013
Development of a vaginal delivery film containing EFdA, a novel anti-HIV nucleoside reverse transcriptase inhibitorWei Zhang, Michael A Parniak, Stefan G Sarafianos, et al.
European Journal of Pharmacology|April 3, 2014
In vitro transport characteristics of EFdA, a novel nucleoside reverse transcriptase inhibitor using Caco-2 and MDCKII cell monolayersWei Zhang, Michael A Parniak, Stefan G Sarafianos, et al.
Pageof 9